Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc

Bullboard Posts

Comment by evenhandon Sep 01, 2015 11:22am

42 Views

Post# 24068348

RE:Mgmt is bloated and draining the coffers

Bloat or foundation for growth? Is the glass half full or half empty? Perhaps you should cut your losses and sell. I know SO'B isn't going to read this BB for advice on how to run the company.

They axed one Inno founder - apparently a non-performer. Some price adjustments being made based on customer advice.

I wish I could hang my "no whining" sign on some of these bullboards (whoops, I guess that is whining too).

Bullboard Posts

Calibre discovers significant gold in Newfoundland